학술논문
주타액선종양 104례에 대한 분석
이용수 0
- 영문명
- A Clinical Analysis of Major Salivary Gland Tumors-104 Cases
- 발행기관
- 대한두경부종양학회
- 저자명
- 김명상(Myung Sang Kim) 김영호(Young Ho Kim) 홍정표(Jung Pyoe Hong) 최은창(Eun Chang Choi) 김광문(Kwang Moon Kim) 홍원표(Won Pyo Hong)
- 간행물 정보
- 『대한두경부종양학회지』제14권 제1호, 40~45쪽, 전체 6쪽
- 주제분류
- 의약학 > 종양학
- 파일형태
- 발행일자
- 1998.05.30
4,000원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
Backgroud and Objectives: Major salivary gland tumor is a rare disease with a largely unknown origin. And also corresponding to the diversity of histopathologic characteristics is an equally wide distribution of clinical behavior that makes treatment decisions difficult. The aim of this study is to analysis the clinical experience of our major salivary gland tumor and to suggest a guidline of management.
Materials and Methods : We studied clinical manifestations and treatment results of 104 patients who were diagnosed as major salivary gland tumors. Tumor site, patient age and sex of the patients were analysed. Histopathologic diagnosis, treatment modality, lymph nodes metastasis, recurrence rate and 5-year survival rate were studied on malignant tumors.
Results:
1) 48 patients were male and 56 patients were female.
2) Benign tumors were 79 cases. They consisted of 57 cases(72%) of parotid tumor, 22 cases(27%) of submandibular tumor. And pleomorphic adenoma was the most common benign tumor.
3) Malignant tumors were 25 cases and were consisted of 19 cases(76%) of parotid tumor, 4 cases(l6%) of submandibular tumor and 2 cases(8%) of sublingual gland tumor with high-grade mucoepidermoid carcinoma as the most common cause.
4) In the malignant tumors, the number of stage I, II tumors was 14 and that of stage III, IV tumors was 11. Neck node metastasis was noted in 8 cases.
5) 8 cases of malignant tumor were died and all of them had high-grade malignancy. And they were dead before 17 months from the time of diagnosis.
6) Mean survival duration in the malignant salivary gland tumor was 56 months.
7) High-grade malignancy had a 5-year survival rate of 57.9%. A 5-year survival rate of TI, T2 patients was 92.9% and that of T3, T4 patients was 36.4%. That of patients who had neck node metastasis was 37.5% and that of those who had tree neck was 82.4%.
Conclusion: The results of this study suggest that the survival rate is dependent on the tumor size, lymph node matastasis and histologic grade. And also the early diagnosis and radical surgery result in the increased survival rate and are effective for prevention of the tumor recurrance.
목차
Abstract
서론
대상 및 방법
결과
고찰
결론
References
해당간행물 수록 논문
- 이하선 심부엽에 발생한 거대 혼합종(Giant Pleomorphic Adenoma) 1예
- 비인강암 환자에서 Cisplatin과 방사선 병합치료시 발생하는 감각신경성 청력손실
- 갑상선 유두상암종의 조직병리학적 소견과 종양침윤과의 연관성
- 갑상선 수술 시의 성대마비의 처치
- 한국인 두경부암 환자에서 제3번 염색체 단완의 결손
- 두경부 이차암의 임상적 고찰
- 소아에서의 갑상선 종양
- 두경부암 환자의 등록 체제
- A Case of Malignant Hemangiopericytoma in Face
- 갑상선 절제술시 동결절편조직검사의 유용성에 대한 평가
- 완료적 갑상선 전 절제술의 임상분석
- 주타액선종양 104례에 대한 분석
- 여포상 갑상선종양에서 신생혈관형성 및 혈관내피성장인자(VEGF)의 발현의 의의
- 하인두암의 임상적 고찰
- 갑상선 악성종양에서 갑상선 전절제술 후 방사성 요오드 치료의 효과
- 양성 갑상선질환과 함께 나타나는 갑상선암
참고문헌
관련논문
의약학 > 종양학분야 BEST
- 방사선 치료에 내성이 유도된 두경부 편평세포암에 대한 종양살상 헤르페스 바이러스의 유전자 치료 효과
- 식도암에서 근치적 절제술 후 방사선치료의 역할
- 두경부암에서 면역회피 기전과 면역항암제 치료
의약학 > 종양학분야 NEW
- Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
- Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck
- Hypofractionated radiation therapy for head and neck cancers in the era of intensity-modulated radiation therapy
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!